The size of the Latin American Western blotting market was worth USD 80.27 million in 2022. This figure is expected to grow and worth USD 104.16 million by 2027, growing at a 5.35% CAGR from 2022 to 2027.
Western blot is often used in research to separate and identify proteins. In this technique, a mixture of proteins is separated based on molecular weight, and thus by type, through gel electrophoresis. These results are then transferred to a membrane producing a band for each protein. The membrane is then incubated with labels antibodies specific to the protein of interest. The unbound antibody is washed off, leaving only the bound antibody to the protein of interest. The bound antibodies are then detected by developing the film. As the antibodies only bind to the protein of interest, only one band should be visible. The thickness of the band corresponds to the amount of protein present; thus, doing a standard can indicate the amount of protein present.
Increasing research activities and R&D spending by pharmaceutical and biotechnology companies and a rise in HIV/AIDS prevalence are the primary driving factors of the market. Factors such as growth in the proteomics market, the increasing number of industry-academic research collaborations, the increase in requirement for personalized medicine, and new product launches are further expected to aid the market's growth. On the other hand, the emergence of alternative technologies is anticipated to harm the market's growth. Furthermore, strict regulations and the requirement of high procedural efficiency for accurate results are likely to challenge the market in the coming years. However, automation in western blotting instruments is expected to provide lucrative opportunities for the market.
The consumables segment holds the largest share in this segment of the market. This is primarily due to the rising use of western blotting in research & diagnosis and an increase in the number of incidences of diseases requiring western blotting for diagnosis. The instruments market is further segmented into gel electrophoresis instruments, blotting systems, and images. The blotting systems segment is expected to account for the largest share in this market segment. This segment's large share can be credited to its high sensitivity, low run time, and high efficiency.
This research report on the Latin American Western Blotting Market has been segmented and sub-segmented into the following categories:
By Product:
By Application:
By End User:
By Country:
The pharmaceutical and biotech companies’ segment will lead with the maximum share of this market segment based on the end-user. However, the research institutions segment is anticipated to have the highest growth rate, followed by the diagnostic laboratories segment with the smallest share in this market segment.
Based on the region, Poor economies and strict government policies will negatively impact mt growth. However, heavy investment by private players in the untapped market is going to boost the market growth.
Prominent companies leading in the Latin American Western blotting market profiled in the report are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., GE Healthcare, Advansta, Inc., LI-COR Biosciences, PerkinElmer Inc., Bio-Techne Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd., and Cell Signaling Technology.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region